nOH
Showing 1 - 25 of 247
Neurogenic Orthostatic Hypotension, Autonomic Failure Trial in Calgary (CO2 ReHaler)
Not yet recruiting
- Neurogenic Orthostatic Hypotension
- Autonomic Failure
- CO2 ReHaler
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 16, 2023
Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy Trial (Ampreloxetine, Placebo)
Not yet recruiting
- Symptomatic Neurogenic Orthostatic Hypotension
- MSA - Multiple System Atrophy
- Ampreloxetine
- Placebo
- (no location specified)
Jan 13, 2023
Neurogenic Orthostatic Hypotension, Multiple System Atrophy (MSA) With Orthostatic Hypotension, Pure Autonomic Failure Trial in
Completed
- Neurogenic Orthostatic Hypotension
- +7 more
- TD-9855
- Placebo
-
Long Beach, California
- +5 more
Aug 30, 2022
Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Miami, Orlando (Ampreloxetine)
Completed
- Symptomatic Neurogenic Orthostatic Hypertension
- nOH
-
Miami, Florida
- +1 more
Sep 7, 2021
Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine)
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
-
Colorado Springs, Colorado
- +54 more
Nov 7, 2022
Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,
Completed
- Symptomatic Neurogenic Orthostatic Hypertension
- nOH
- Ampreloxetine <Dose A>
- +4 more
-
Tempe, ArizonaTheravance Biopharma Investigational Site
Apr 19, 2021
Orthostatic Hypotension, Neurogenic Orthostatic Hypotension Trial in Calgary (Sequential Gas Delivery)
Recruiting
- Orthostatic Hypotension
- Neurogenic Orthostatic Hypotension
- Sequential Gas Delivery
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 31, 2022
Parkinson Disease, Falls Patient Trial in Phoenix (Droxidopa, Placebo)
Unknown status
- Parkinson Disease
- Falls Patient
- Droxidopa
- Placebo
-
Phoenix, ArizonaBarrow Neurological Institute at St. Joseph's Hospital and Medic
Oct 25, 2019
Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
- +3 more
- ampreloxetine
- Placebo
-
Sun City, Arizona
- +81 more
Dec 29, 2022
Parkinson Disease, Neurogenic Orthostatic Hypotension Trial in Houston (Droxidopa, Placebo)
Unknown status
- Parkinson Disease
- Neurogenic Orthostatic Hypotension
- Droxidopa
- Placebo
-
Houston, TexasHouston Methodist Hospital
Sep 18, 2019
Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine, Placebo)
Completed
- Symptomatic Neurogenic Orthostatic Hypotension
- ampreloxetine
- Placebo
-
Sun City, Arizona
- +124 more
Sep 15, 2021
Pain, Quality of Life, Health Behavior Trial in Hillerød (Exercise training)
Recruiting
- Pain
- +2 more
- Exercise training
-
Hillerød, Region Hovedstaden, Denmark
- +1 more
Apr 5, 2022
Parkinson Disease, Orthostatic Hypotension Trial in Salt Lake City (Autonomic testing on and off levodopa)
Recruiting
- Parkinson Disease
- Orthostatic Hypotension
- Autonomic testing on and off levodopa
-
Salt Lake City, UtahUniversity of Utah
Aug 1, 2022
Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))
Terminated
- Stomach Cancer
- S-1 (452500ACH)
- OXALIPLATIN (205803BIJ)
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Dec 6, 2022
Cardiovascular Health, Physical Function Trial in Seoul (Golden Circle)
Completed
- Cardiovascular Health
- Physical Function
- Golden Circle
-
Seoul, Korea, Republic ofMokdong Senior Welfare Center
Aug 9, 2023
What is Rate of Surgical Treatment in Adult Displaced Distal
Active, not recruiting
- Distal Radius Fracture
-
Hillerød, DenmarkNorth Zealand Hospital
Feb 1, 2023
Friedreich Ataxia, Cardiomyopathies, Cardiac Hypertrophy Trial in New York (AAVrh.10hFXN, serotype rh.10 adeno-associated virus
Recruiting
- Friedreich Ataxia
- +3 more
- AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN
- Prednisone
-
New York, New YorkWeill Cornell Medicine
Jul 15, 2022
Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)
Recruiting
- Gastric Cancer, Adjuvant Chemotherapy, XO
- Docetaxel and capecitabine and oxaliplatin
- capecitabine and oxaliplatin
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
A Multi-Center, Prospective, Observational Study to Evaluate
Recruiting
- Gastroesophageal Reflux Disease
- Fexuprazan Hydrochloride
-
Busan, Korea, Republic ofKosin University Gospel Hospital
Dec 13, 2022
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Recruiting
- Parkinson's Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 19, 2022
Breast Cancer Female Trial in Bani Suwayf (MetFORMIN 500 Mg Oral Tablet, Chemotherapy)
Completed
- Breast Cancer Female
- MetFORMIN 500 Mg Oral Tablet
- Chemotherapy
-
Banī Suwayf, EgyptMarian S. Boshra
May 2, 2023
Cubital Tunnel Syndrome Trial in New York (Standard Conservative Treatment, Nerve Gliding Exercises)
Recruiting
- Cubital Tunnel Syndrome
- Standard Conservative Treatment
- Nerve Gliding Exercises
-
New York, New YorkNew York University School of Medicine
Oct 26, 2021
Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- CVI-VZV-001
- Shingrix
-
Seoul, Eunpyeong-gu, Korea, Republic of
- +1 more
Nov 20, 2023
Long-term Outcome After Cleft-lift for Pilonidal Sinus Disease
Completed
- Pilonidal Sinus
-
Hillerød, DenmarkNordsjaellands Hospital
Apr 26, 2022